| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update JH Karnes, AE Rettie, AA Somogyi, R Huddart, AE Fohner, CM Formea, ... Clinical Pharmacology & Therapeutics 109 (2), 302-309, 2021 | 133 | 2021 |
| Standardized biogeographic grouping system for annotating populations in pharmacogenetic research R Huddart, AE Fohner, M Whirl‐Carrillo, GL Wojcik, CR Gignoux, ... Clinical Pharmacology & Therapeutics 105 (5), 1256-1262, 2019 | 103 | 2019 |
| Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women G Jones, K Trajanoska, AJ Santanasto, N Stringa, CL Kuo, JL Atkins, ... Nature communications 12 (1), 654, 2021 | 101 | 2021 |
| Genome-wide association analyses of physical activity and sedentary behavior provide insights into underlying mechanisms and roles in disease prevention Z Wang, A Emmerich, NJ Pillon, T Moore, D Hemerich, MC Cornelis, ... Nature genetics 54 (9), 1332-1344, 2022 | 82 | 2022 |
| Selective deregulation in chemokine signaling pathways of CD4+ CD25hiCD127lo/− regulatory T cells in human allergic asthma KD Nguyen, C Vanichsarn, A Fohner, KC Nadeau Journal of Allergy and Clinical Immunology 123 (4), 933-939. e10, 2009 | 80 | 2009 |
| PharmGKB summary: macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics AE Fohner, A Sparreboom, RB Altman, TE Klein Pharmacogenetics and genomics 27 (4), 164-167, 2017 | 79 | 2017 |
| XCL1 enhances regulatory activities of CD4+ CD25highCD127low/− T cells in human allergic asthma KD Nguyen, A Fohner, JD Booker, C Dong, AM Krensky, KC Nadeau The Journal of Immunology 181 (8), 5386-5395, 2008 | 72 | 2008 |
| Pharmacogenetics in American Indian populations: analysis of: CYP2D6:: CYP3A4:: CYP3A5:, and: CYP2C9: in the Confederated Salish and Kootenai Tribes A Fohner, LAI Muzquiz, MA Austin, A Gaedigk, A Gordon, T Thornton, ... Pharmacogenetics and genomics 23 (8), 403-414, 2013 | 67 | 2013 |
| Assessing clinical heterogeneity in sepsis through treatment patterns and machine learning AE Fohner, JD Greene, BL Lawson, JH Chen, P Kipnis, GJ Escobar, ... Journal of the American Medical Informatics Association 26 (12), 1466-1477, 2019 | 49 | 2019 |
| Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9:: VKORC1:: CYP4F2:: CYP4F11:: GGCX AE Fohner, R Robinson, J Yracheta, DA Dillard, B Schilling, B Khan, ... Pharmacogenetics and genomics 25 (7), 343-353, 2015 | 46 | 2015 |
| Cytochrome P450 genetic variation associated with tamoxifen biotransformation in American Indian and Alaska native people BA Khan, R Robinson, AE Fohner, LAI Muzquiz, BD Schilling, JA Beans, ... Clinical and translational science 11 (3), 312-321, 2018 | 39 | 2018 |
| The CYP2C19 intron 2 branch point SNP is the ancestral polymorphism contributing to the poor metabolizer phenotype in livers with CYP2C19* 35 and CYP2C19* 2 alleles AS Chaudhry, B Prasad, Y Shirasaka, A Fohner, D Finkelstein, Y Fan, ... Drug Metabolism and Disposition 43 (8), 1226-1235, 2015 | 39 | 2015 |
| Genetics, diet, and season are associated with serum 25-hydroxycholecalciferol concentration in a Yup’ik study population from Southwestern Alaska AE Fohner, Z Wang, J Yracheta, DM O’Brien, SE Hopkins, J Black, J Philip, ... The Journal of nutrition 146 (2), 318-325, 2016 | 38 | 2016 |
| Advancing precision public health using human genomics: examples from the field and future research opportunities MC Roberts, AE Fohner, L Landry, DL Olstad, AK Smit, E Turbitt, CG Allen Genome medicine 13 (1), 97, 2021 | 30 | 2021 |
| PharmGKB summary: very important pharmacogene information for: ABCG2 AE Fohner, DJ Brackman, KM Giacomini, RB Altman, TE Klein Pharmacogenetics and genomics 27 (11), 420-427, 2017 | 30 | 2017 |
| PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics AE Fohner, EM McDonagh, JP Clancy, MW Carrillo, RB Altman, TE Klein Pharmacogenetics and genomics 27 (1), 39-42, 2017 | 28 | 2017 |
| Democratizing precision medicine through community engagement AE Fohner, KG Volk, EL Woodahl Clinical pharmacology and therapeutics 106 (3), 488, 2019 | 25 | 2019 |
| Pre-statistical considerations for harmonization of cognitive instruments: Harmonization of ARIC, CARDIA, CHS, FHS, MESA, and NOMAS EM Briceño, AL Gross, BJ Giordani, JJ Manly, RF Gottesman, MSV Elkind, ... Journal of Alzheimer's Disease 83 (4), 1803-1813, 2021 | 21 | 2021 |
| Natural killer cells, gamma delta T cells and classical monocytes are associated with systolic blood pressure in the multi-ethnic study of atherosclerosis (MESA) JAC Delaney, NC Olson, CM Sitlani, AE Fohner, SA Huber, AL Landay, ... BMC Cardiovascular Disorders 21, 1-9, 2021 | 17 | 2021 |
| VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People LM Henderson, RF Robinson, L Ray, BA Khan, T Li, DA Dillard, ... Clinical and Translational Science 12 (3), 312-320, 2019 | 17 | 2019 |
